AwardProf. Matthias Tschöp Receives Berthold Medal of the German Society of Endocrinology for Scientific Excellence
New Clinical Study Aims to Prevent Type 1 Diabetes in ChildrenThe new ‘SINT1A‘ study explores the potential of a specific probiotic to strengthen the immune system early-on in children with increased genetic risk of type 1 diabetes, and thus prevent its development. SINT1A is led by Helmholtz Zentrum München and part of the international GPPAD initiative.
Scientists Discover a Promising New Target for Diabetes TreatmentResearchers have discovered a novel and druggable insulin inhibitory receptor, named inceptor.
Uncovering basic mechanisms of intestinal stem cell self-renewal and differentiation promises new approaches to treat diseasesTargeting endocrine dysfunction at an early stage by stimulating the formation of specific enteroendocrine cells from intestinal stem cells could be a promising regenerative approach for diabetes therapy.
Coronavirus Update
Due to the ongoing coronavirus pandemic, some precautions are being taken on the premises of Helmholtz Zentrum München to protect employees from infection and to contain the spread of the coronavirus. All measures are constantly being reviewed. Further information on the current regulations and our contribution to the fight against the pandemic can be found by following the link below.
Focus
Helmholtz Zentrum München by numbers
Research fingerprint
Translate
Discovery that addresses real world problems and offers tangible medical solutions.
Science and Society
We actively involve the general public, to disseminate and raise awareness about the current state of research. Learn more about our services.
Distinguished national programs
Sustainable research
Graduate Program and Research Schools
The Helmholtz Graduate School Environmental Health (HELENA) develops the next generation of internationally competitive researchers.
